Skip to main content

Table 2 Sero-prevalence of viral hepatitis markers among the study population (n = 260)

From: Hepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar es Salaam, Tanzania

Marker No (%) 95% CI
HAV-IgM antibodies 8 (3.1) 1.3 – 6.0
HBsAg 45 (17.3) 12.9 – 22.5
HBc IgM antibodies 6 (2.3) 0.9 – 5.0
HCV Ab 47 (18.1) 13.6 – 23.3
HBsAg & HBc IgM 4 (1.6) 0.4 – 3.9
HBsAg & HCV Ab 10 (3.9) 1.9 – 7.0
Any viral marker 90(34.6) 28.9 – 40.7